Oral estramustine phosphate (Estracyt®): a broad phase II studyHALPERN, J; CATANE, R.Journal of medicine (Westbury). 1984, Vol 15, Num 1, pp 35-43, issn 0025-7850Article

Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrolDAPONTE, D; DE PAUW, M; FRYSZMAN, A et al.British journal of urology (Print). 1983, Vol 55, Num 4, pp 408-412, issn 0007-1331Article

STUDIES ON THE CONVERSION OF OESTRADIOL LINKED TO A CYTOSTATIC AGENTS (ESTRACYT) IN VARIOUS RAT TISSUES.H NONOISAETER PA.1976; ACTA ENDOCRINOL.; DANEM.; DA. 1976; VOL. 82; NO 3; PP. 661-672; BIBL. 17 REF.Article

Cooperative clinical trials of the national prostatic cancer project: protocol 900SCHMIDT, J. D.The Prostate. 1984, Vol 5, Num 4, pp 387-399, issn 0270-4137Article

Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerveKANJE, M; DEINUM, J; WALLIN, M et al.Cancer research (Baltimore). 1985, Vol 45, Num 5, pp 2234-2239, issn 0008-5472Article

Immunological effects of diethylstilbestrol and estramustine phosphateHAUKAAS, S. A.Scandinavian journal of urology and nephrology. Supplementum. 1984, Num 83, issn 0300-8886, 77 p.Serial Issue

HORMONAL EFFECTS OF DIFFERENT DOSES OF ESTRAMUSTINE PHOSPHATE (ESTRACYT^REG.) IN PATIENTS WITH PROSTATIC CARCINOMAFRITJOFSSON A; NORLEN BJ; HOGBERG B et al.1981; SCAND. J. UROL. NEPHROL.; ISSN 0036-5599; SWE; DA. 1981; VOL. 15; NO 1; PP. 37-44; BIBL. 21 REF.Article

METABOLISM OF ESTRAMUSTINE PHOSPHATE (ESTRACYT^REG.) IN PATIENTS WITH PROSTATIC CARCINOMAANDERSSON SB; GUNNARSSON PO; NILSSON T et al.1981; EUR. J. DRUG METAB. PHARMACOKINET.; ISSN 0378-7966; CHE; DA. 1981; VOL. 6; NO 2; PP. 149-154; BIBL. 25 REF.Article

TREATMENT OF STAGE D HORMONE-RESISTANT CARCINOMA OF THE PROSTATE WITH ESTRAMUSTINE PHOSPHATEBENSON RC; WEAR JB; GILL GM et al.1979; J. UROL.; USA; DA. 1979; VOL. 121; NO 4; PP. 452-454; BIBL. 12 REF.Article

HORMONE CHANGES IN PATIENTS WITH PROSTATIC CARCINOMA DURING TREATMENT WITH ESTRAMUSTINE PHOSPHATE.FOSSA SD; FOSSA J; AAKVAAG A et al.1977; J. UROL.; U.S.A.; DA. 1977; VOL. 118; NO 6; PP. 1013-1018; BIBL. 22 REF.Article

STUDIES ON A NITROGEN MUSTARD OF ESTRADIOL IN DOGS AND RATS.KIRDANI RY; MURPHY GP; SANDBERG AA et al.1977; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1977; VOL. 155; NO 1; PP. 94-98; BIBL. 13 REF.Article

ESTRAMUSTINE PHOSPHATE (EMCYT) AS TREATMENT FOR METASTATIC RENAL CARCINOMASWANSON DA; JOHNSON DE.1981; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1981; VOL. 17; NO 4; PP. 344-346; BIBL. 10 REF.Article

L'ESTRAMUSTINFOSFATO NEL TRATTAMENTO DEL CARCINOMA DELLA PROSTATA INSENSIBILE AGLI ESTROGENI = L'ESTRAMUSTINPHOSPHATE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE INSENSIBLE AUX OESTROGENESPICCINNO A; GUIDO A; DIRIENZO U et al.1978; UROLOGIA; ITA; DA. 1978; VOL. 45; NO 3; PP. 236-240; BIBL. 6 REF.Article

ESTROGEN RECEPTORS INTERACTION WITH ESTRACYT AND DEGRADATION PRODUCTS, A BIOCHEMICAL STUDY ON A POTENTIAL AGENT IN THE TREATMENT OF BREAST CANCER.LECLERCQ G; HEUSON JC; DEBOEL MC et al.1976; EUROP. J. DRUG METABOL. PHARMACOKINET.; FR.; DA. 1976; VOL. 1; NO 2; PP. 77-84; BIBL. 21 REF.Article

Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3HARTLEY-ASP, B.The Prostate. 1984, Vol 5, Num 1, pp 93-100, issn 0270-4137Article

Estramustine phosphate-reduced proliferation of murine and human cell lines and murine transplantable tumorsPAVELIĆ, K; ZGRADIĆ, I; OSMAK, M et al.Research in experimental medicine. 1985, Vol 185, Num 3, pp 233-243, issn 0300-9130Article

ESTRACYT-THERAPIE BEIM FORTGESCHRITTENEN PROSTATAKARZINOM: DERZEITIGER STAND UND EIGENE ERGEBNISSE = TRAITEMENT PAR L'ESTRACYT DANS LE CANCER AVANCE DE LA PROSTATE: ETAT ACTUEL ET RESULTATS PERSONNELSNAGEL R; LEISTENSCHNEIDER W.1983; UROLOGE. AUSGABE A; ISSN 0340-2592; DEU; DA. 1983; VOL. 22; NO 3; PP. 162-166; ABS. ENG; BIBL. 23 REF.Article

OBSERVATIONS OF PROLONGED USE OF ORAL EMCYT IN PROSTATIC CANCER PATIENTSSLACK NH; BRADY MF; MURPHY GP et al.1982; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1982; VOL. 20; NO 5; PP. 515-523; BIBL. 24 REF.Article

EFFICACITE THERAPEUTIQUE DE L'ESTRAMUSTINE PHOSPHATE (ESTRACYT) POUR LE CANCER DE LA PROSTATEKATAYAMA T; SHIMAZAKI J; OTSUKA K et al.1978; ACTA UROL. JAP.; JPN; DA. 1978; VOL. 24; NO 10; PP. 879-888; ABS. ENG; BIBL. 42 REF.Article

STUDIES OF ANTIPROSTATIC AGENTS IN THE BABOON = ETUDE D'AGENTS ANTIPROSTATIQUES CHEZ LE BABOUINMUNTZING J; VARKARAKIS MJ; YAMANAKA H et al.1974; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1974; VOL. 146; NO 3; PP. 849-854; BIBL. 1/2P.Article

ESTRACYT (NSC89199) AS A SUBSTRATE FOR PHOSPHATASES IN HUMAN SERUM = L'ESTRACYT (NSC89199) UTILISE COMME SUBSTRAT DES PHOSPHATASES DANS LE SERUM HUMAINTRITSCH GL; SHUKLA SK; MITTELMAN A et al.1974; INVEST. UROL.; U.S.A.; DA. 1974; VOL. 12; NO 1; PP. 38-39; BIBL. 9REF.Article

COMPARISON OF ESTRAMUSTINE PHOSPHATE AND VINCRISTINE ALONE OR IN COMBINATION FOR PATIENTS WITH ADVANCED HORMONE REFRACTORY, PREVIOUSLY IRRADIATED CARCINOMA OF THE PROSTATESOLOWAY MS; DE KERNION JB; GIBBONS RP et al.1981; J. UROL.; ISSN 0022-5347; USA; DA. 1981; VOL. 125; NO 5; PP. 664-667; BIBL. 17 REF.Article

PILOT STUDY ON THE GROWTH INHIBITION BY ESTRAMUSTINE PHOSPHATE (ESTRACYL) OF RAT MAMMARY TUMOURS SENSITIVE AND INTENSITIVE TO OESTROGENMUNTZING J; JENSEN G; HOGBERG B et al.1979; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1979; VOL. 44; NO 1; PP. 1-6; BIBL. 22 REF.Article

IN VIVO INTERACTION BETWEEN STEROIDAL ALKYLATING AGENTS AND OESTROGEN RECEPTORS IN RABBIT UTERI.ASAI M; TAKEUCHI H; OKADA H et al.1978; ACTA ENDOCRINOL.; DANEM.; DA. 1978; VOL. 87; NO 1; PP. 173-180; BIBL. 22 REF.Article

BLOCKIERUNG VON STEROIDHORMONREZEPTOREN BEI PROSTATAKARZINOMEN. = BLOCAGES DES RECEPTEURS HORMONAUX STEROIDIENS DANS LES CANCERS DE LA PROSTATEPFITZENMAIER N; SCHMID W; ROHL L et al.1978; THERAPIEWOCHE; DTSCH.; DA. 1978; VOL. 28; NO 10; PP. 1978-1983 (2P.); BIBL. 3 REF.Article